Concepedia

Publication | Closed Access

Mid-Term Outcomes of Minimally Invasive Direct Coronary Artery Bypass Grafting

DOI

12

Citations

0

References

2014

Year

Mathias Van Hemelrijck, Jovana Pavicevic, Herman Tolboom, Tomáš Holubec, Volkmar Falk, Stephan Jacobs, Diana Reser
The Thoracic and Cardiovascular Surgeon

Abstract

MIDCAB is a safe procedure with low postoperative morbidity, mortality, and favorable mid-term MACCE-free survival in selected patients that should be discussed in a heart team setting to evaluate the "ideal" individual treatment option.